Abstract:Background Epigenetic alternation is a common contributing factor to neoplastic transformation. Although previous studies have reported a cluster of aberrant promoter methylation changes associated with silencing of tumor suppressor genes, little is known concerning their sequential DNA methylation changes during the carcinogenetic process. The aim of the present study was to address a genome-wide search for identifying potentially important methylated changes and investigate the onset and pattern of methylation changes during the progression of colorectal neoplasia. Methods A three-phase design was employed in this study. In the screening phase, DNA methylation profile of 12 pairs of colorectal cancer (CRC) and adjacent normal tissues was analyzed by using the Illumina MethylationEPIC BeadChip. Significant CpG sites were selected based on a cross-validation analysis from The Cancer Genome Atlas (TCGA) database. Methylation levels of candidate CpGs were assessed using pyrosequencing in the training dataset (tumor lesions and adjacent normal tissues from 46 CRCs) and the validation dataset (tumor lesions and paired normal tissues from 13 hyperplastic polyps, 129 adenomas, and 256 CRCs). A linear mixed-effects model was used to examine the incremental changes of DNA methylation during the progression of colorectal neoplasia. Results The comparisons between normal and tumor samples in the screening phase revealed an extensive CRC-specific methylomic pattern with 174,006 (21%) methylated CpG sites, of which 22,232 (13%) were hyermethylated and 151,774 (87%) were hypomethylated. Hypermethylation mostly occurred in CpG islands with an overlap of gene promoters, while hypomethylation tended to be mapped far away from functional regions. Further cross validation analysis from TCGA dataset confirmed 265 hypermethylated promoters coupling with downregulated gene expression. Among which, hypermethylated changes in MEEPD2 promoter was successfully replicated in both training and validation phase. Significant hypermethylation appeared since precursor lesions with an extensive modification in CRCs. The linear mixed-effects modeling analysis found that a cumulative pattern of MPPED2 methylation changes from normal mucosa to hyperplastic polyp to adenoma, and to carcinoma ( P < 0.001). Conclusions Our findings indicate that epigenetic alterations of MPPED2 promoter region appear sequentially during the colorectal neoplastic progression. It might be able to serve as a promising biomarker for early diagnosis and stage surveillance of colorectal tumorigenesis.

P16 CpG Region Methylation of the Colorectal Cancer and Its Association with Clinicopathological Characteristics

P16 Gene Methylation in Colorectal Cancers Associated with Duke's Staging.

Methylation of P16 Promotor's CpG Region and Its Association with Clinic Pathological Characteristics of Gliomas

Methylation Status of P16 Gene in Colorectal Carcinoma and Normal Colonic Mucosa.

Detection of Hypermethylation of P16 Gene from Colorectal Cancer Patient

Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer

The effects of p16 gene methylation on the risk of non-small cell lung cancer

Study of P16 Tumor Suppressor Gene with Methylation-Specific PCR

[DNA Methylation of ZIC1 and KLOTHO Gene Promoters in Colorectal Carcinomas and Its Clinicopathological Significance].

Methylation of p16 Gene in the Invasive Ductal Bbreast Cancer

Hypermethylation of CpG island at p16 gene promoter in gastric carcinomas

Correlation of p16 gene methylation with protein expression in gastric cancer and its clinical significance

Methylation of CpG Islands of P16 Associated with Progression of Primary Gastric Carcinomas

Aberrant Methylation in CpG Islands of P15 and P16 Tumor Suppressor Genes in Pancreatic Cancer Tissue

Association of Low P16ink4a and P15ink4b Mrnas Expression with Their Cpg Islands Methylation with Human Hepatocellular Carcinogenesis

Correlation Between Methylation of the P16 Promoter and Cervical Cancer Incidence.

Analysis of aberrant methylation of p16 gene promoter in tissue from gastric cancer patients

Detection of aberrant p16 methylation in the serum of colorectal cancer patients

An Analysis of the Relationship between 5'CpG Island Methylation of P16 Gene and Tumor Aggressive Behavior in Transitional Cell Carcinomas of Uronary Bladded

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

The specific methylation characteristics of cancer related genes in Chinese colorectal cancer patients